Molecular Analysis for Combination Therapy Choice (ComboMATCH) Protocol EAY191-A3, A ComboMATCH Treatment Trial: Palbociclib and Binimetinib in RAS-Mutant Cancers (NCT05554367)
To screen and assign patients to ComboMATCH treatment trials.
Why this Research Matters
To screen and assign patients to ComboMATCH treatment trials.
Who can Participate
Adult
Detailed eligibility criteria is available on ClinicalTrials.gov. These requirements will be discussed with your doctor and/or study representative. Visit ClinicalTrials.gov to learn more about this study.
Study ID
Protocol Number: 24-0233
More information available at ClinicalTrials.gov: NCT05554367
Meet the Team
Principal Investigator
Categories
Locations
- Harmony Campus
- Greeley Campus
- Poudre Valley Hospital Medical Center of the Rockies University of Colorado Hospital
- Outpatient CTRC